XTSXNLH
Market cap16mUSD
Dec 24, Last price
0.28CAD
1D
10.00%
1Q
14.58%
IPO
111.54%
Name
Nova Leap Health Corp
Chart & Performance
P/E
—
P/S
0.63
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
12.21%
Rev. gr., 5y
20.37%
Revenues
26m
-7.18%
Net income
-1m
L+26.20%
CFO
2m
+111.08%
Earnings
Mar 05, 2025
Profile
Nova Leap Health Corp. provides home and home health care services in the United States and Canada. Its services include dementia care, companionship, personal and respite care, cooking and meal preparation, bathing, dressing, grooming, housekeeping, errands, transportation, and medication reminders by nursing staff. Nova Leap Health Corp. was incorporated in 2015 and is headquartered in Halifax, Canada.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | 26,179 -7.18% | 28,205 32.55% | 21,279 22.93% | |||||
Cost of revenue | 24,834 | 27,911 | 21,649 | |||||
Unusual Expense (Income) | ||||||||
NOPBT | 1,345 | 294 | (370) | |||||
NOPBT Margin | 5.14% | 1.04% | ||||||
Operating Taxes | 311 | (371) | 713 | |||||
Tax Rate | 23.14% | |||||||
NOPAT | 1,034 | 665 | (1,082) | |||||
Net income | (1,055) 26.20% | (836) -147.47% | 1,761 40.15% | |||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | 1,788 | 4,380 | ||||||
BB yield | -9.21% | -9.25% | ||||||
| Debt | ||||||||
Debt current | 484 | 2,689 | 4,279 | |||||
Long-term debt | 2,104 | 2,770 | 3,236 | |||||
Deferred revenue | ||||||||
Other long-term liabilities | 141 | |||||||
Net debt | 1,694 | 4,186 | 5,781 | |||||
| Cash flow | ||||||||
Cash from operating activities | 2,155 | 1,021 | 2,180 | |||||
CAPEX | (28) | (71) | ||||||
Cash from investing activities | (23) | (56) | (7,402) | |||||
Cash from financing activities | (2,516) | (1,414) | 4,330 | |||||
FCF | 2,099 | 1,054 | (3,860) | |||||
| Balance | ||||||||
Cash | 895 | 1,273 | 1,733 | |||||
Long term investments | ||||||||
Excess cash | 669 | |||||||
Stockholders' equity | 15,934 | 16,551 | 16,699 | |||||
Invested Capital | 19,595 | 22,649 | 23,952 | |||||
ROIC | 4.90% | 2.85% | ||||||
ROCE | 6.87% | 1.30% | ||||||
| EV | ||||||||
Common stock shares outstanding | 86,209 | 77,654 | 77,654 | |||||
Price | 0.30 20.00% | 0.25 -59.02% | 0.61 -18.67% | |||||
Market cap | 25,863 33.22% | 19,413 -59.02% | 47,369 -4.93% | |||||
EV | 27,557 | 23,600 | 53,150 | |||||
EBITDA | 2,230 | 1,650 | 492 | |||||
EV/EBITDA | 12.36 | 14.31 | 108.13 | |||||
Interest | 271 | 401 | ||||||
Interest/NOPBT | 92.23% | |||||||